Spinal Anaesthesia with Bupivacaine versus Ropivacaine in Caesarean section

Comparison of the effect of intrathecal Bupivacaine with intrathecal Ropivacaine on Hemodynamic of patients under Elective Caesarean Section

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190506043495N1

Enrollment

Registered

2019-05-18

Start date

2019-05-22

Completion date

Unknown

Last updated

2019-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Anaesthesia in Caesarean section.

Interventions

Intervention 1: Intervention group: Amp. Bupivacaine 0.5% 12.5 mg, Single dose, Intrathecally. Intervention 2: Intervention group: Amp. Ropivacaine 0.5%, 17.5 mg, Single dose, Intrathecally.

Eligibility

Sex/Gender

Female

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Term Pregnant women 18 - 40 Y/O Physical health class (ASA score): 1-2 Candidated for Caesarean section

Exclusion criteria

Exclusion criteria: Dissatisfaction of Patient for Spinal Anaesthesia Presence of Contraindication for Regional Anaesthesia Pre-term or post-term pregnancy Age40 y/o Physical health class (ASA score) > 2 Urgency surgery

Design outcomes

Primary

Measure	Time frame
Heart rate. Timepoint: Before Spinal Anaesthesia and every 2 minutes interval after Spinal Anaesthesia. Method of measurement: Heart monitoring device.	—

Secondary

Measure	Time frame
Systolic blood pressure. Timepoint: Before Spinal Anaesthesia and every 2 minutes interval after Spinal Anaesthesia. Method of measurement: Non invasive automated blood pressure device.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Ahmad ghazi

Ardabil University of Medical Sciences

alavi@arums.ac.ir+98 45 3324 8888

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026